BrookfieldCME Group

Brookfield vs CME Group

Large global asset manager owning real estate and infrastructure vs Global futures and options exchange operator with clearing services. Which is the better buy for your portfolio in June 2026? Plain-English answer below.

Brookfield Asset Management runs a global alternative investment platform managing hundreds of billions across infrastructure, real estate, credit, and private equity, growing fee-related earnings as ...

Why It’s Moving

Brookfield

Brookfield’s BN is drawing support from upbeat analyst calls and a clean-energy growth story.

  • Analyst forecasts remain constructive, with consensus targets implying meaningful upside and reinforcing the view that the market is still paying for Brookfield’s long-term earnings power.
  • Investor attention is centered on Brookfield’s diversified platform, where infrastructure, renewables, and asset management give BN multiple ways to grow cash flow rather than relying on one business line.
  • The broader backdrop is helping: demand for dependable power and infrastructure remains strong, which keeps Brookfield’s exposure to energy transition and large-scale capital projects in focus.
Sentiment:
🐃Bullish
CME Group

CME slides as analysts focus on volatility risks and a tougher near-term setup

  • Erste Group cut its view to hold, pointing to volatility concerns that could limit near-term upside for CME’s derivatives-heavy business.
  • KBW said fears around perpetual futures look overblown, but the debate itself underscores how sensitive CME’s earnings outlook is to changes in trading volatility and market structure.
  • Broader analyst sentiment remains mixed, with some models still flagging modest downside risk even as others see CME as a defensive play when markets get choppy.
Sentiment:
🌋Volatile

Investment Analysis

Pros

  • Brookfield Corp benefits from diversified, long-duration real asset exposure across infrastructure, renewables, real estate, and private equity, providing resilience to economic cycles.
  • The company’s global scale and presence in multiple high-growth geographies enable access to proprietary deal flow and sizeable investment opportunities not available to smaller competitors.
  • Strong institutional partnerships and substantial third-party capital under management generate recurring, high-margin asset management fees and reduce dependence on balance sheet leverage.

Considerations

  • Brookfield’s elevated leverage and debt-to-equity ratio increase sensitivity to rising interest rates and refinancing risks in volatile credit markets.
  • Complex corporate structure and multiple subsidiaries create challenges in transparency, governance, and consistent investor communication.
  • Exposure to illiquid, long-term real assets may result in valuation volatility and limited flexibility during periods of market stress or liquidity contraction.

Pros

  • CME Group operates the world’s largest and most liquid derivatives marketplace, with a near-monopoly position in key global benchmark products for interest rates, equity indices, commodities, and FX.
  • The business model is highly scalable and cash-generative, driven by high-margin electronic trading, recurring clearing revenues, and minimal operational leverage in a largely fixed-cost infrastructure.
  • Global regulatory emphasis on central clearing and risk management supports long-term structural growth in demand for CME’s core products and services.

Considerations

  • CME Group’s earnings are sensitive to trading volumes, which can fluctuate significantly with macro volatility, interest rate cycles, and investor risk appetite.
  • The company faces increasing competition from alternative trading venues, regional exchanges, and over-the-counter markets, which may erode pricing power over time.
  • Regulatory changes or shifts in clearing mandates could disrupt business flows, while market structure reforms may reduce the profitability of certain legacy products.

Brookfield (BN) Next Earnings Date

Brookfield Corp. (BN) has an estimated next earnings publication date of August 6, 2026, based on its historical reporting schedule, though the company has not officially confirmed this specific date yet. This upcoming report will cover the financial results for the second quarter of 2026 (Q2 2026). Investors should anticipate the announcement to occur before the market opens, followed by a conference call for commentary and Q&A. Please note that this date is an estimate derived from past patterns and may be subject to adjustment by the company.

CME Group (CME) Next Earnings Date

The next earnings date for CME Group is expected on July 22, 2026, before the market opens. This report will cover Q2 2026 results. CME has not officially confirmed the date yet, but the July timing matches its typical quarterly reporting pattern.

Buy BN or CME in Nemo

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions

BN
BN$43.63
vs
CME
CME$243.58
Buy BN